Editor Search Announcement for Blood Advances
Thank you for your interest in the Editor-in-Chief position of Blood Advances. Any questions should be emailed to firstname.lastname@example.org. All applications must be sent by email to email@example.com by April 20, 2020.
To apply, all ASH members must include the following documents:
- A letter of intent detailing relevant experience and explaining why this position is of interest;
- A current CV;
- A vision statement of no more than 2,000 words
Blood Advances Editor-in-Chief Job Description
Blood Advances is the peer-reviewed, online-only, open access journal of the American Society of Hematology that was launched in 2016. The journal maintains a broad scope addressing the entire field of hematology and publishes unique original content, including Blood Advances Talks (brief audio reviews) and Point-Blood AdvancesCounterpoints, where invited experts debate controversial topics in hematology. Blood Advances is also the official home of the ASH Clinical Guidelines, which are widely impacting clinical practice. Being the Editor-in-Chief of Blood Advances is an opportunity to shape a rising journal and make a difference in the discussion and practice of hematology.
The Blood Advances Editor-in-Chief sets the editorial direction of the journal. The editorial mandate of the Editor-in-Chief is to publish innovative, high-quality, and useful research in hematology; identify emerging areas of importance and actively solicit valuable work being done in those areas; and promote the scientific exchange of ideas to advance the field of hematology and the subspecialty areas represented in the content of Blood Advances. The Editor-in-Chief serves at the pleasure of the American Society of Hematology’s Executive Committee.
The Editor-in-Chief is responsible for the conduct and quality of the journal’s editorial peer review and for the scientific content of Blood Advances, including the selection of its Associate Editors and the Editorial Board. The Editor-in-Chief’s routine duties include, but are not limited to, assigning new manuscripts to appropriate Associate Editors; promoting and/or inviting content that will add value to the journal (current examples are Reviews, Clinical Guidelines, and Drug Advances); promoting features that will add value to the journal; resolving ethical misconduct and conflict of interest cases that may result in the publication of errata and/or retractions; and approving cover art and lineups for Blood Advances issues. The amount of time needed to fulfill the obligations of the Blood Advances Editor-in-Chief is significant, and time must be allocated on a daily basis in order to maintain the level of quality Blood Advances has established.
The Editor-in-Chief is required to attend various ASH meetings, including, but not limited to, the ASH Annual Meeting, Program Committee, and Scientific Committee meetings, the Executive Committee Spring Retreat, the December Executive Committee meeting, and Publication Committee meetings. The Editor-in-Chief also chairs the Blood Advances Editor Retreat meeting. ASH pays an honorarium along with the Editor’s reasonable travel, lodging, and related expenses in accordance with ASH’s travel and expense reimbursement policies.
The Editor-in-Chief serves for an initial term of five years. The Editor-in-Chief contract may be renewed one time, at the discretion of the Executive Committee and with the approval of the Editor-in-Chief, for a mutually agreed extension not to exceed five years.
Qualifications, Knowledge, and Skills Required
The Editor-in-Chief must hold a medical degree and/or PhD in hematology or a related field. Strong leadership qualities and capacity to constructively work with scientific/medical researchers, editors, authors, and reviewers are essential. Candidates with hands-on experience with team building and supervisory experience are required. The successful candidate will be highly regarded as a scientist, with numerous high-quality publications and prior experience as a reviewer. Prior experience as an associate editor or editor of a scientific journal is preferred. Knowledge of the publishing environment and familiarity with manuscript submission platforms are desirable, and a high level of organizational skills and the ability to meet tight deadlines and work under pressure are essential.
About Blood Advances
Blood Advances is a semimonthly medical journal published by the American Society of Hematology. It is the first journal to join the Blood family in 70 years and is a peer-reviewed, online-only, open access journal. Under the direction of founding editor-in-chief Robert Negrin, MD, Stanford University Medical Center, Stanford, CA, the journal debuted on November 29, 2016.
Blood Advances provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. The journal covers all aspects of hematology, both benign and malignant, including disorders of leukocytes, erythrocytes, and platelets; hemostatic mechanisms; vascular biology; immunology; and hematologic oncology. All articles undergo a rigorous peer review and are selected on the basis of the originality of the findings, the superior quality of the work described, and the clarity of presentation.
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology.
For background information to help you with your application, please familiarize yourself with the links about Blood Advances below: